Granahan Investment Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,267
| Closed | -$906K | – | 191 |
|
|
2021
Q3 | $906K | Sell |
6,267
-3,487
| -36% | -$504K | 0.02% | 188 |
|
|
2021
Q2 | $1.8M | Sell |
9,754
-272
| -3% | -$50.2K | 0.03% | 181 |
|
|
2021
Q1 | $2.47M | Sell |
10,026
-2,289
| -19% | -$563K | 0.05% | 166 |
|
|
2020
Q4 | $3.47M | Sell |
12,315
-2,511
| -17% | -$708K | 0.08% | 152 |
|
|
2020
Q3 | $3.56M | Buy |
14,826
+1,086
| +8% | +$261K | 0.12% | 125 |
|
|
2020
Q2 | $4.56M | Buy |
+13,740
| New | +$4.56M | 0.16% | 110 |
|